RO5323441
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for RO5323441, covering 2016-11-02 to 2016-11-02. Get the full timeline:
Most recent: Clinical Trial Update: A Dose-Finding and Exploratory Study of RO5323441 in Combination With Sorafenib in Patients With Hepatocellular Carcinoma [Phase 1]